CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands		Total	Common Class A	Common Class B	Common Stock Common Class A		Common Stock Common Class B		Additional Paid-in Capital	(Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021	[1]				4,668,678		134,839
Beginning balance at Dec. 31, 2021		$ 652,205			$ 47	[1]	$ 1	[1]	$ 1,672,588	$ (1,020,142)	$ (289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(11,073)								(11,073)
Compensation expense related to granting of stock awards (in shares)	[1]				(1,978)
Compensation expense related to granting of stock awards		2,698							2,698
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")(in shares)	[1]				2,034
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")		177							177
Purchase of vested employee restricted stock units (in shares)	[1]				(20,729)
Purchase of vested employee restricted stock units		(1,839)							(1,839)
Payment of dividends on common stock		(174)							(174)	0
Dividend equivalents, net of forfeitures		202								202	0
Net unrealized gain (loss) on derivatives		1,223								0	1,223
Ending balance (in shares) at Mar. 31, 2022	[1]				4,648,005		134,839
Ending balance at Mar. 31, 2022		643,419			$ 47	[1]	$ 1	[1]	1,673,450	(1,031,013)	934
Beginning balance (in shares) at Dec. 31, 2021	[1]				4,668,678		134,839
Beginning balance at Dec. 31, 2021		652,205			$ 47	[1]	$ 1	[1]	1,672,588	(1,020,142)	(289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(152,821)
Net unrealized gain (loss) on derivatives		3,198
Ending balance (in shares) at Sep. 30, 2022	[1]				4,710,739		134,839
Ending balance at Sep. 30, 2022		507,011			$ 48	[1]	$ 1	[1]	1,676,808	(1,172,755)	2,909
Beginning balance (in shares) at Mar. 31, 2022	[1]				4,648,005		134,839
Beginning balance at Mar. 31, 2022		643,419			$ 47	[1]	$ 1	[1]	1,673,450	(1,031,013)	934
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(773)								(773)
Compensation expense related to granting of stock awards (in shares)	[1]				57,934
Compensation expense related to granting of stock awards		2,481			$ 1	[1]			2,480
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")(in shares)	[1]				4,706
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")		132							132
Purchase of vested employee restricted stock units (in shares)	[1]				(760)
Purchase of vested employee restricted stock units		(51)							(51)
Payment of dividends on common stock		(4)							(4)
Dividend equivalents, net of forfeitures		4								4
Net unrealized gain (loss) on derivatives		553									553
Ending balance (in shares) at Jun. 30, 2022	[1]				4,709,885		134,839
Ending balance at Jun. 30, 2022		645,761			$ 48	[1]	$ 1	[1]	1,676,007	(1,031,782)	1,487
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(140,975)								(140,975)
Compensation expense related to granting of stock awards (in shares)	[1]				(5,606)
Compensation expense related to granting of stock awards		726			$ 0	[1]			726
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")(in shares)	[1]				6,606
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")		77							77
Purchase of vested employee restricted stock units (in shares)	[1]				(146)
Purchase of vested employee restricted stock units		(2)							(2)
Dividend equivalents, net of forfeitures		2							2
Net unrealized gain (loss) on derivatives		1,422									1,422
Ending balance (in shares) at Sep. 30, 2022	[1]				4,710,739		134,839
Ending balance at Sep. 30, 2022		507,011			$ 48	[1]	$ 1	[1]	1,676,808	(1,172,755)	2,909
Beginning balance (in shares) at Dec. 31, 2022			4,705,328	134,839	4,705,328	[2]	134,839	[2]
Beginning balance at Dec. 31, 2022		520,619			$ 47	[2]	$ 1	[2]	1,678,247	(1,160,618)	2,942
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(35,901)								(35,901)
Compensation expense related to granting of stock awards (in shares)	[2]				195,724
Compensation expense related to granting of stock awards		1,949			$ 2	[2]			1,947
Purchase of vested employee restricted stock units (in shares)	[2]				(27,072)
Purchase of vested employee restricted stock units		(127)							(127)
Payment of dividends on common stock		(60)							(60)
Dividend equivalents, net of forfeitures		22								22
Net unrealized gain (loss) on derivatives		(840)									(840)
Ending balance (in shares) at Mar. 31, 2023	[2]				4,873,980		134,839
Ending balance at Mar. 31, 2023		485,662			$ 49	[2]	$ 1	[2]	1,680,007	(1,196,497)	2,102
Beginning balance (in shares) at Dec. 31, 2022			4,705,328	134,839	4,705,328	[2]	134,839	[2]
Beginning balance at Dec. 31, 2022		520,619			$ 47	[2]	$ 1	[2]	1,678,247	(1,160,618)	2,942
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		$ (396,036)
Repurchase of common stock (in shares)		0
Net unrealized gain (loss) on derivatives		$ (1,598)
Ending balance (in shares) at Sep. 30, 2023			4,866,563	134,839	4,866,563	[2]	134,839	[2]
Ending balance at Sep. 30, 2023		126,623			$ 49	[2]	$ 1	[2]	1,681,823	(1,556,594)	1,344
Beginning balance (in shares) at Mar. 31, 2023	[2]				4,873,980		134,839
Beginning balance at Mar. 31, 2023		485,662			$ 49	[2]	$ 1	[2]	1,680,007	(1,196,497)	2,102
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(125,802)								(125,802)
Compensation expense related to granting of stock awards (in shares)	[2]				(7,449)
Compensation expense related to granting of stock awards		1,049							1,049
Repurchase of common stock (in shares)	[2]				(215)
Repurchase of common stock		(1)							(1)
Purchase of vested employee restricted stock units (in shares)	[2]				(557)
Purchase of vested employee restricted stock units		(2)							(2)
Payment of dividends on common stock		21							21
Dividend equivalents, net of forfeitures		38								38
Net unrealized gain (loss) on derivatives		(391)									(391)
Ending balance (in shares) at Jun. 30, 2023	[2]				4,865,759		134,839
Ending balance at Jun. 30, 2023		360,574			$ 49	[2]	$ 1	[2]	1,681,074	(1,322,261)	1,711
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(234,333)								(234,333)
Compensation expense related to granting of stock awards (in shares)	[2]				950
Compensation expense related to granting of stock awards		749							749
Purchase of vested employee restricted stock units (in shares)	[2]				(146)
Purchase of vested employee restricted stock units		0
Net unrealized gain (loss) on derivatives		(367)									(367)
Ending balance (in shares) at Sep. 30, 2023			4,866,563	134,839	4,866,563	[2]	134,839	[2]
Ending balance at Sep. 30, 2023		$ 126,623			$ 49	[2]	$ 1	[2]	$ 1,681,823	$ (1,556,594)	$ 1,344

[1] (1) Share counts have been retroactively adjusted to reflect the effect of the reverse stock split.

[2] (1) Share counts have been retroactively adjusted to reflect the effect of the reverse stock split.